1. Home
  2. BCRX vs LC Comparison

BCRX vs LC Comparison

Compare BCRX & LC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCRX
  • LC
  • Stock Information
  • Founded
  • BCRX 1986
  • LC 2006
  • Country
  • BCRX United States
  • LC United States
  • Employees
  • BCRX N/A
  • LC N/A
  • Industry
  • BCRX Biotechnology: Biological Products (No Diagnostic Substances)
  • LC Finance: Consumer Services
  • Sector
  • BCRX Health Care
  • LC Finance
  • Exchange
  • BCRX Nasdaq
  • LC Nasdaq
  • Market Cap
  • BCRX 1.7B
  • LC 1.8B
  • IPO Year
  • BCRX 1994
  • LC 2014
  • Fundamental
  • Price
  • BCRX $7.86
  • LC $10.41
  • Analyst Decision
  • BCRX Buy
  • LC Strong Buy
  • Analyst Count
  • BCRX 6
  • LC 8
  • Target Price
  • BCRX $15.67
  • LC $16.00
  • AVG Volume (30 Days)
  • BCRX 3.6M
  • LC 1.5M
  • Earning Date
  • BCRX 05-05-2025
  • LC 04-29-2025
  • Dividend Yield
  • BCRX N/A
  • LC N/A
  • EPS Growth
  • BCRX N/A
  • LC 25.35
  • EPS
  • BCRX N/A
  • LC 0.45
  • Revenue
  • BCRX $450,712,000.00
  • LC $1,160,928,000.00
  • Revenue This Year
  • BCRX $27.66
  • LC N/A
  • Revenue Next Year
  • BCRX $13.59
  • LC $18.39
  • P/E Ratio
  • BCRX N/A
  • LC $23.13
  • Revenue Growth
  • BCRX 36.00
  • LC 2.25
  • 52 Week Low
  • BCRX $4.03
  • LC $7.48
  • 52 Week High
  • BCRX $9.50
  • LC $18.75
  • Technical
  • Relative Strength Index (RSI)
  • BCRX 46.95
  • LC 34.84
  • Support Level
  • BCRX $7.44
  • LC $10.83
  • Resistance Level
  • BCRX $8.12
  • LC $11.70
  • Average True Range (ATR)
  • BCRX 0.27
  • LC 0.46
  • MACD
  • BCRX 0.03
  • LC 0.11
  • Stochastic Oscillator
  • BCRX 71.74
  • LC 21.04

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About LC LendingClub Corporation

LendingClub Corp is a company engaged in operating an online lending marketplace platform that connects borrowers and investors for the provision of the loan facility. It offers investors access to an asset class that has generally been closed to many investors and only available on a limited basis to institutional investors. The company through the platform offers loan products such as personal, education and patient finance, small business, and auto to interested investors. It generates a majority of the revenue from the transaction fees received from the platform's role in accepting and decisioning applications on behalf of the bank partners to enable loan originations.

Share on Social Networks: